| Title |
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
|
|---|---|
| Published in |
Cardiovascular Drugs and Therapy, January 2006
|
| DOI | 10.1007/s10557-005-5686-z |
| Pubmed ID | |
| Authors |
Eric Bruckert, Gilles Hayem, Sylvie Dejager, Caroline Yau, Bernard Bégaud |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Egypt | 1 | 17% |
| United States | 1 | 17% |
| Spain | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Scientists | 1 | 17% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 466 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 1% |
| Canada | 2 | <1% |
| Switzerland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Singapore | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 454 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 84 | 18% |
| Student > Master | 63 | 14% |
| Researcher | 58 | 12% |
| Student > Ph. D. Student | 46 | 10% |
| Student > Postgraduate | 32 | 7% |
| Other | 101 | 22% |
| Unknown | 82 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 188 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 39 | 8% |
| Agricultural and Biological Sciences | 37 | 8% |
| Biochemistry, Genetics and Molecular Biology | 30 | 6% |
| Nursing and Health Professions | 12 | 3% |
| Other | 50 | 11% |
| Unknown | 110 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 98. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2024.
All research outputs
#436,825
of 25,837,817 outputs
Outputs from Cardiovascular Drugs and Therapy
#4
of 785 outputs
Outputs of similar age
#843
of 173,669 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#1
of 4 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 785 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them